Pharmacy India

Pharmacy India is your ultimate destination for pharmacy exam preparation and career advancement. Discover top-notch study materials, daily quizzes, and expert courses for pharmacy exams like RRB Pharmacist, GPAT, and NIPER JEE, D.Pharma Exit Exam, etc.

Tag: NTLA-2002

The US FDA designates Intellia’s NTLA-2002, a regenerative medicine advanced therapy to treat hereditary angioedema.

The US FDA designates Intellia’s NTLA-2002, a regenerative medicine advanced therapy to treat hereditary angioedema.

The US Food and Drug Administration (FDA) has designated NTLA-2002 for the treatment of hereditary angioedema as a Regenerative Medicine Advanced Treatment (RMAT), according to Intellia Therapeutics, Inc., a leading clinical-stage genome editing business (HAE). NTLA-2002 is a CRISPR-based in…

Back to top

This will close in 0 seconds

Registration Form

Login

This will close in 0 seconds